Embryo Implantation

Promising results announced for Emfilermin

Published in Women's Health Weekly, July 31st, 2003

Serono, S.A., (SRA) announced at the ESHRE (European Society for Human Reproduction and Embryology) Congress in Madrid positive results of a first proof of concept study of emfilermin (r-hLIF) for improving embryo implantation in women with recurrent implantation failure (RIF).

"This study indicates that emfilermin has good prospects of increasing pregnancy rates in those women in whom embryos have previously failed to implant, helping more couples to fulfill their dream of having a child," said Peter Brinsden, medical director of Bourn Hall in Cambridgeshire, England. "The results of this exploratory study confirmed that those patients who had a suspected problem with...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2003-07-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry